SCPS (Scopus BioPharma) Float Percentage Of Total Shares Outstanding: 81.32% (As of Jun. 26, 2026)


What is Scopus BioPharma Float Percentage Of Total Shares Outstanding?

Scopus BioPharma SCPS Float Percentage Of Total Shares Outstanding is 81.32% as of Jun. 26, 2026.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Scopus BioPharma's float shares is 34.22 Mil. Scopus BioPharma's total shares outstanding is 42.08 Mil. Scopus BioPharma's float percentage of total shares outstanding is 81.32%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Scopus BioPharma's Insider Ownership is 1.21%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Scopus BioPharma's Institutional Ownership is 0.00%.

Scopus BioPharma Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Scopus BioPharma's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=34.22/42.08
=81.32%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 81.32% mean?
Scopus BioPharma (SCPS) has a Float Percentage Of Total Shares Outstanding of 81.32% as of Jun. 26, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Scopus BioPharma and its competitors.
Is Scopus BioPharma's Float Percentage Of Total Shares Outstanding too high?
Scopus BioPharma's current Float Percentage Of Total Shares Outstanding is 81.32%.
How does Scopus BioPharma's Float Percentage Of Total Shares Outstanding compare to AMPE and DRMA?
Scopus BioPharma's Float Percentage Of Total Shares Outstanding of 81.32% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Scopus BioPharma and its competitors. Scopus BioPharma's current Float Percentage Of Total Shares Outstanding is 81.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scopus BioPharma stock overvalued right now?
Scopus BioPharma (SCPS) has a current Float Percentage Of Total Shares Outstanding of 81.32%. The current Float Percentage Of Total Shares Outstanding is 81.32%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Scopus BioPharma (SCPS), the current Float Percentage Of Total Shares Outstanding is 81.32% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scopus BioPharma Business Description

Address 420 Lexington Avenue, Suite 300, New York, NY, USA, 10170
Scopus BioPharma Inc a biotechnology company focused on developing therapeutics targeting the endocannabinoid system. The endocannabinoid system is comprised of chemical compounds, or cannabinoids, that interact with cannabinoid receptors which are located throughout the body. Its product candidate comprises CO-sTiRNA, which is a STAT3 inhibitor gene therapy and MRI-1867.